文献速递精神分裂症与精神病性障碍会诊联络精神医学

精神病性障碍代谢风险计算器(PsyMetRiC)的开发与外部验证

Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis.
PubMed 文献 · Lancet Psychiatry · 2021-06-01

PsyMetRiC 是一个针对 16-35 岁精神病性障碍患者、预测 6 年内新发代谢综合征的风险算法,基于基线常规信息开发了包含和不包含生化指标的两个版本,并在英国早期干预服务中完成外部验证,区分度良好。

要点

  • PsyMetRiC 可用于预测 16-35 岁精神病性障碍患者 6 年内新发代谢综合征风险。
  • 完整模型外部验证 C 统计量为 0·75(95% CI 0·69-0·80),区分度良好。
  • 在 0·18 cutoff 下,完整模型净获益提升 7·95%,相当于多检出 47% 代谢综合征病例。

核心结论

  • PsyMetRiC 是针对年轻精神病性障碍患者、预测新发代谢综合征的适龄算法,有潜力辅助早期干预服务的临床决策。

研究设计与样本

  • 采用强制进入法开发两个 PsyMetRiC 版本:完整模型含年龄、性别、 ethnicity、BMI、吸烟状态、代谢活跃抗精神病药处方、HDL 和甘油三酯;部分模型不含生化结果。
  • 敏感性分析在英国出生队列中 18 岁且有精神病性障碍风险的参与者中进行。
  • 主要评估区分度(C 统计量)和校准(校准图),并进行了决策曲线分析,并制作了在线数据可视化应用。
  • 开发样本 651 例,验证样本 510 例,敏感性分析样本 505 例。

主要发现

  • 内部验证 C 统计量:完整模型 0·80(95% CI 0·74-0·86),部分模型 0·79(95% CI 0·73-0·84)。
  • 外部验证 C 统计量:完整模型 0·75(95% CI 0·69-0·80),部分模型 0·74(95% CI 0·67-0·79)。
  • 完整模型校准良好,部分模型存在轻微校准不良的证据。
  • 在 cutoff 0·18 时,完整模型净获益提升 7·95%(敏感度 75%,95% CI 66-82;特异度 74%,95% CI 71-78),相当于多检出 47% 的代谢综合征病例。

关键数值与推荐

  • PsyMetRiC 完整模型 cutoff 0·18 时,敏感度 75%(95% CI 66-82),特异度 74%(95% CI 71-78)。
  • 完整模型外部验证 C 统计量 0·75(95% CI 0·69-0·80)。
  • 部分模型外部验证 C 统计量 0·74(95% CI 0·67-0·79)。

临床怎么用

  • 可用于 16-35 岁精神病性障碍患者早期干预服务中,个体化评估代谢综合征风险。
  • 风险预测结果可辅助抗精神病药物选择及生活方式干预的知情决策。
  • 完整模型需生化指标,部分模型可用于无法获取生化结果时。

局限性

  • 部分模型存在轻微校准不良的证据。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Young people with psychosis are at high risk of developing cardiometabolic disorders; however, there is no suitable cardiometabolic risk prediction algorithm for this group. We aimed to develop and externally validate a cardiometabolic risk prediction algorithm for young people with psychosis. METHODS: We developed the Psychosis Metabolic Risk Calculator (PsyMetRiC) to predict up to 6-year risk of incident metabolic syndrome in young people (aged 16-35 years) with psychosis from commonly recorded information at baseline. We developed two PsyMetRiC versions using the forced entry method: a full model (including age, sex, ethnicity, body-mass index, smoking status, prescription of a metabolically active antipsychotic medication, HDL concentration, and triglyceride concentration) and a partial model excluding biochemical results. PsyMetRiC was developed using data from two UK psychosis early intervention services (Jan 1, 2013, to Nov 4, 2020) and externally validated in another UK early intervention service (Jan 1, 2012, to June 3, 2020). A sensitivity analysis was done in UK birth cohort participants (aged 18 years) who were at risk of developing psychosis. Algorithm performance was assessed primarily via discrimination (C statistic) and calibration (calibration plots). We did a decision curve analysis and produced an online data-visualisation app. FINDINGS: 651 patients were included in the development samples, 510 in the validation sample, and 505 in the sensitivity analysis sample. PsyMetRiC performed well at internal (full model: C 0·80, 95% CI 0·74-0·86; partial model: 0·79, 0·73-0·84) and external validation (full model: 0·75, 0·69-0·80; and partial model: 0·74, 0·67-0·79). Calibration of the full model was good, but there was evidence of slight miscalibration of the partial model. At a cutoff score of 0·18, in the full model PsyMetRiC improved net benefit by 7·95% (sensitivity 75%, 95% CI 66-82; specificity 74%, 71-78), equivalent to detecting an additional 47% of metabolic syndrome cases. INTERPRETATION: We have developed an age-appropriate algorithm to predict the risk of incident metabolic syndrome, a precursor of cardiometabolic morbidity and mortality, in young people with psychosis. PsyMetRiC has the potential to become a valuable resource for early intervention service clinicians and could enable personalised, informed health-care decisions regarding choice of antipsychotic medication and lifestyle interventions. FUNDING: National Institute for Health Research and Wellcome Trust.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Perry BI, Osimo EF, Upthegrove R, et al. Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis. Lancet Psychiatry. 2021. PMID: 34087113. doi:10.1016/S2215-0366(21)00114-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。